Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors
This was the stock's second consecutive day of losses.
Arcus Biosciences Shares Hit 52-Week Low After $150M Stock Offering
Arcus Biosciences shares were down 14%, to $11.33, after the company priced a $150 million stock offering. Shares of the biopharmaceutical company hit their 52-week low of $10.65 earlier in the ...
Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Arcus Biosciences (RCUS) to $18 from $20 and keeps a Buy rating on the shares after the ...
Analysts Offer Insights on Healthcare Companies: Cybin (CYBN) and Corbus Pharmaceuticals (CRBP)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cybin (CYBN – Research Report) and Corbus ...
Arcus Biosciences stock dips after pricing $150M offering
Arcus Biosciences (NYSE:RCUS) shares dipped 4% after the company priced a stock offering to raise approximately $150 million. The offering consists of 13,636,364 shares of common stock issued at ...